512 related articles for article (PubMed ID: 21103659)
1. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial.
Visser J; Ulander VM; Helmerhorst FM; Lampinen K; Morin-Papunen L; Bloemenkamp KW; Kaaja RJ
Thromb Haemost; 2011 Feb; 105(2):295-301. PubMed ID: 21103659
[TBL] [Abstract][Full Text] [Related]
2. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.
Kaandorp SP; Goddijn M; van der Post JA; Hutten BA; Verhoeve HR; Hamulyák K; Mol BW; Folkeringa N; Nahuis M; Papatsonis DN; Büller HR; van der Veen F; Middeldorp S
N Engl J Med; 2010 Apr; 362(17):1586-96. PubMed ID: 20335572
[TBL] [Abstract][Full Text] [Related]
3. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
4. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
[TBL] [Abstract][Full Text] [Related]
5. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.
de Jong PG; Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD004734. PubMed ID: 24995856
[TBL] [Abstract][Full Text] [Related]
6. A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study.
Tempfer CB; Kurz C; Bentz EK; Unfried G; Walch K; Czizek U; Huber JC
Fertil Steril; 2006 Jul; 86(1):145-8. PubMed ID: 16716321
[TBL] [Abstract][Full Text] [Related]
7. [Treatment with enoxaparin adapted to the fertility programs in women with recurrent abortion and thrombophilia].
Sarto A; Rocha M; Geller M; Capmany C; Martínez M; Quintans C; Donaldson M; Pasqualini RS
Medicina (B Aires); 2001; 61(4):406-12. PubMed ID: 11563168
[TBL] [Abstract][Full Text] [Related]
8. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study.
Brenner B; Bar J; Ellis M; Yarom I; Yohai D; Samueloff A;
Fertil Steril; 2005 Sep; 84(3):770-3. PubMed ID: 16169422
[TBL] [Abstract][Full Text] [Related]
9. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
de Jong PG; Quenby S; Bloemenkamp KW; Braams-Lisman BA; de Bruin JP; Coomarasamy A; David M; DeSancho MT; van der Heijden OW; Hoek A; Hutten BA; Jochmans K; Koks CA; Kuchenbecker WK; Mol BW; Torrance HL; Scheepers HC; Stephenson MD; Verhoeve HR; Visser J; de Vries JI; Goddijn M; Middeldorp S
Trials; 2015 May; 16():208. PubMed ID: 25947329
[TBL] [Abstract][Full Text] [Related]
10. Outcome of pregnancies in women with thrombophilic disorders.
Sucak A; Acar K; Celen S; Danisman N; Sucak GT
J Obstet Gynaecol; 2010; 30(8):847-51. PubMed ID: 21126128
[TBL] [Abstract][Full Text] [Related]
11. Use of heparin in women with early and late miscarriages with and without thrombophilia.
Monien S; Kadecki O; Baumgarten S; Salama A; Dörner T; Kiesewetter H
Clin Appl Thromb Hemost; 2009 Dec; 15(6):636-44. PubMed ID: 19666941
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
13. Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
Elmahashi MO; Elbareg AM; Essadi FM; Ashur BM; Adam I
BMC Res Notes; 2014 Jan; 7():23. PubMed ID: 24405979
[TBL] [Abstract][Full Text] [Related]
14. Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind placebo-controlled trial.
Pasquier E; de Saint Martin L; Bohec C; Chauleur C; Bretelle F; Marhic G; Le Gal G; Debarge V; Lecomte F; Denoual-Ziad C; Lejeune-Saada V; Douvier S; Heisert M; Mottier D
Blood; 2015 Apr; 125(14):2200-5. PubMed ID: 25636341
[TBL] [Abstract][Full Text] [Related]
15. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J
Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355
[TBL] [Abstract][Full Text] [Related]
16. Testing for inherited thrombophilia in recurrent miscarriage.
de Jong PG; Goddijn M; Middeldorp S
Semin Reprod Med; 2011 Nov; 29(6):540-7. PubMed ID: 22161466
[TBL] [Abstract][Full Text] [Related]
17. Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.
Ramidi G; Khan N; Glueck CJ; Wang P; Goldenberg N
Transl Res; 2009 Jan; 153(1):33-43. PubMed ID: 19100956
[TBL] [Abstract][Full Text] [Related]
18. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
19. Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia.
Carp H; Dolitzky M; Inbal A
J Thromb Haemost; 2003 Mar; 1(3):433-8. PubMed ID: 12871446
[TBL] [Abstract][Full Text] [Related]
20. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study.
Fawzy M; Shokeir T; El-Tatongy M; Warda O; El-Refaiey AA; Mosbah A
Arch Gynecol Obstet; 2008 Jul; 278(1):33-8. PubMed ID: 18071727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
